VNStockNews.com - In 2010, Hau Giang Pharmaceutical Joint Stock Co (coded SHG) estimated to reach whole year revenue of 1.92 trillion dong, and pre-tax profit of about 370 billion dong, surpassing 20 percent against the year plan.
Meanwhile, Imexpharm Pharmaceutical Joint Stock Co (coded IMP) announced to gain accumulative profit of 97 billion dong.
Cuu Long Pharmaceutical Joint Stock Co expected to earn whole year revenue of 750 billion dong, after tax profit of 70-75 billion dong.
OPC Pharmaceutical Joint Stock Co (OPC)'s total revenue in 2010 was posted at 350 billion dong, and pre-tax profit of 62 billion dong.
Lastly, Traphaco expected to fulfil 2010 year plan when gaining whole year revenue of 900 billion dong and after tax profit of 61 billion dong.
